Literature DB >> 23143811

Off-label, but on-target: use of regadenoson with exercise.

Robert C Hendel, Lauren Frost.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23143811     DOI： 10.1007/s12350-012-9643-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  15 in total

1.  What does off-label prescribing really mean?

Authors:  Patrick G O'Malley
Journal:  Arch Intern Med       Date:  2012-05-28

2.  Shifting terrain in the regulation of off-label promotion of pharmaceuticals.

Authors:  Michelle M Mello; David M Studdert; Troyen A Brennan
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

3.  Ten common questions (and their answers) about off-label drug use.

Authors:  Christopher M Wittich; Christopher M Burkle; William L Lanier
Journal:  Mayo Clin Proc       Date:  2012-08-06       Impact factor: 7.616

4.  A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

Authors:  Matthew W Parker; Donna Chelle Morales; Hanna B Slim; Alan W Ahlberg; Deborah M Katten; Giselle Cyr; Shishir Mathur; Afrooz Ardestani; Dimitrios Barmpouletos; Geeta Swamy Iyah; Steven M Borer; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

5.  Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging.

Authors:  M D Elliott; T A Holly; S M Leonard; R C Hendel
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

6.  Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery disease.

Authors:  G Jamil; A W Ahlberg; M D Elliott; R C Hendel; T Holly; C C McGill; M Sarkis; M P White; J F Mather; D D Waters; G V Heller
Journal:  Am J Cardiol       Date:  1999-08-15       Impact factor: 2.778

7.  Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients.

Authors:  Deborah H Kwon; Manuel D Cerqueira; Ron Young; Penny Houghtaling; Elizabeth Lieber; Venu Menon; Richard C Brunken; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2010-04-23       Impact factor: 5.952

8.  Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

Authors:  Ami E Iskandrian; Timothy M Bateman; Luiz Belardinelli; Brent Blackburn; Manuel D Cerqueira; Robert C Hendel; Hsiao Lieu; John J Mahmarian; Ann Olmsted; S Richard Underwood; João Vitola; Whedy Wang
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

9.  Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.

Authors:  Sara L Partington; Viswanatha Lanka; Jon Hainer; Ron Blankstein; Hicham Skali; Daniel E Forman; Marcelo F Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2012-05-08       Impact factor: 5.952

10.  The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.

Authors:  Gregory S Thomas; Randall C Thompson; Michael I Miyamoto; Tze K Ip; Deborah L Rice; Douglas Milikien; Hsiao D Lieu; Vandana S Mathur
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952
View more
  5 in total

1.  A helping hand for regadenoson tests.

Authors:  Preeti Kansal; Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2015-10-22       Impact factor: 5.952

2.  Regadenoson and exercise myocardial perfusion imaging: the courtship continues.

Authors:  Harkawal S Hundal; Gregory S Thomas
Journal:  J Nucl Cardiol       Date:  2013-06       Impact factor: 5.952

3.  Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.

Authors:  Jesse A Doran; Waseem Sajjad; Marabel D Schneider; Rohit Gupta; Maria L Mackin; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2016-03-29       Impact factor: 5.952

4.  New exercise-dipyridamole combined test for nuclear cardiology in insufficient effort: appropriate diagnostic sensitivity keeping exercise prognosis.

Authors:  Inés Vidal; Mario Beretta; Omar Alonso; Fernando Mut
Journal:  Arq Bras Cardiol       Date:  2015-05-29       Impact factor: 2.000

5.  Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System.

Authors:  Jenny Shapiro; Ortal Iancu; Ashley M Jacobi; Matthew S McNeill; Rolf Turk; Garrett R Rettig; Ido Amit; Adi Tovin-Recht; Zohar Yakhini; Mark A Behlke; Ayal Hendel
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-04       Impact factor: 6.698
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.